Login
Home
Charts
Search
Watchlist
Products

Tata Chemicals Ltd

TATACHEM·NSE
674.00-2.98%Tue, 22 Sept '26

Tata Chemicals Ltd

TATACHEM
NSE
674.00
-2.98%
|Tue, 22 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
17,171Cr
Close
Close Price
674.00
Industry
Industry
Chemicals - Inorganic - Caustic Soda/Soda Ash
PE
Price To Earnings
PS
Price To Sales
1.14
Revenue
Revenue
15,120Cr
Rev Gr TTM
Revenue Growth TTM
2.04%
PAT Gr TTM
PAT Growth TTM
-484.21%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
3,9983,7303,4753,7893,9993,5903,5093,7193,8773,5503,4384,255
Growth YoY
Revenue Growth YoY%
-5.7-10.1-21.1-10.20.0-3.81.0-1.9-3.0-1.1-2.014.4
Expenses
ExpensesCr
3,1793,1883,0323,2153,3813,1563,1823,0703,3403,2053,1643,700
Operating Profit
Operating ProfitCr
819542443574618434327649537345274555
OPM
OPM%
20.514.512.815.215.412.19.317.413.89.78.013.0
Other Income
Other IncomeCr
17598-838101152-101113812821-1,76039
Interest Expense
Interest ExpenseCr
145132130133145148137147144146153148
Depreciation
DepreciationCr
234246271273277280293280285293343336
PBT
PBTCr
615262-796269348-4-92360236-73-1,982110
Tax
TaxCr
1206822948117-254482-413450
PAT
PATCr
495194-841190267-21-49316154-69-2,11660
Growth YoY
PAT Growth YoY%
-27.2-54.4-221.5-67.6-46.1-110.894.266.3-42.3-228.6-4,218.4-81.0
NPM
NPM%
12.45.2-24.25.06.7-0.6-1.48.54.0-1.9-61.51.4
EPS
EPS
16.86.2-33.45.97.6-2.1-2.29.93.0-3.6-83.7-0.7
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
3,9983,7303,4753,7893,9993,5903,5093,7193,8773,5503,4384,255
Growth YoY
Revenue Growth YoY%
-5.7-10.1-21.1-10.20.0-3.81.0-1.9-3.0-1.1-2.014.4
Expenses
ExpensesCr
3,1793,1883,0323,2153,3813,1563,1823,0703,3403,2053,1643,700
Operating Profit
Operating ProfitCr
819542443574618434327649537345274555
OPM
OPM%
20.514.512.815.215.412.19.317.413.89.78.013.0
Other Income
Other IncomeCr
17598-838101152-101113812821-1,76039
Interest Expense
Interest ExpenseCr
145132130133145148137147144146153148
Depreciation
DepreciationCr
234246271273277280293280285293343336
PBT
PBTCr
615262-796269348-4-92360236-73-1,982110
Tax
TaxCr
1206822948117-254482-413450
PAT
PATCr
495194-841190267-21-49316154-69-2,11660
Growth YoY
PAT Growth YoY%
-27.2-54.4-221.5-67.6-46.1-110.894.266.3-42.3-228.6-4,218.4-81.0
NPM
NPM%
12.45.2-24.25.06.7-0.6-1.48.54.0-1.9-61.51.4
EPS
EPS
16.86.2-33.45.97.6-2.1-2.29.93.0-3.6-83.7-0.7

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
14,87310,34610,27010,33710,35710,20012,62216,78915,42114,88714,58415,120
Growth
Revenue Growth%
-13.6-30.4-0.70.70.2-1.523.833.0-8.2-3.5-2.02.0
Expenses
ExpensesCr
12,7818,2528,0798,5568,4088,69910,31712,96712,57412,93412,77913,409
Operating Profit
Operating ProfitCr
2,0922,0942,1911,7801,9491,5012,3053,8222,8471,9531,8051,711
OPM
OPM%
14.120.221.317.218.814.718.322.818.513.112.411.3
Other Income
Other IncomeCr
140182273579307260471216-507254-1,473-1,572
Interest Expense
Interest ExpenseCr
525297326354342367303406530563590591
Depreciation
DepreciationCr
5265125185696667598068929801,1231,2011,257
PBT
PBTCr
1,1801,4671,6201,4371,2486341,6672,740830521-1,459-1,709
Tax
TaxCr
24834660274220198266288381167256262
PAT
PATCr
9321,1211,5601,1631,0284361,4002,452449354-1,715-1,971
Growth
PAT Growth%
15.420.339.2-25.5-11.6-57.6221.075.1-81.7-21.2-584.5-484.2
NPM
NPM%
6.310.815.211.39.94.311.114.62.92.4-11.8-13.0
EPS
EPS
13.217.041.519.7275.010.149.491.010.59.2-74.4-85.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
14,87310,34610,27010,33710,35710,20012,62216,78915,42114,88714,58415,120
Growth
Revenue Growth%
-13.6-30.4-0.70.70.2-1.523.833.0-8.2-3.5-2.02.0
Expenses
ExpensesCr
12,7818,2528,0798,5568,4088,69910,31712,96712,57412,93412,77913,409
Operating Profit
Operating ProfitCr
2,0922,0942,1911,7801,9491,5012,3053,8222,8471,9531,8051,711
OPM
OPM%
14.120.221.317.218.814.718.322.818.513.112.411.3
Other Income
Other IncomeCr
140182273579307260471216-507254-1,473-1,572
Interest Expense
Interest ExpenseCr
525297326354342367303406530563590591
Depreciation
DepreciationCr
5265125185696667598068929801,1231,2011,257
PBT
PBTCr
1,1801,4671,6201,4371,2486341,6672,740830521-1,459-1,709
Tax
TaxCr
24834660274220198266288381167256262
PAT
PATCr
9321,1211,5601,1631,0284361,4002,452449354-1,715-1,971
Growth
PAT Growth%
15.420.339.2-25.5-11.6-57.6221.075.1-81.7-21.2-584.5-484.2
NPM
NPM%
6.310.815.211.39.94.311.114.62.92.4-11.8-13.0
EPS
EPS
13.217.041.519.7275.010.149.491.010.59.2-74.4-85.0

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
2552552552552552552552552550255
Reserves
ReservesCr
6,6007,65310,84712,08612,64314,03517,99819,46621,98621,33920,951
Current Liabilities
Current LiabilitiesCr
5,0255,6063,7033,9497,0254,4637,0964,9046,0556,1396,743
Non Current Liabilities
Non Current LiabilitiesCr
9,8777,4738,3567,7007,0028,7317,5909,5387,5879,14010,113
Total Liabilities
Total LiabilitiesCr
24,35523,61025,87926,90527,68928,33733,84335,08436,75637,78039,031
Current Assets
Current AssetsCr
7,5797,3749,0408,0987,7996,6468,7458,1646,3676,7207,206
Non Current Assets
Non Current AssetsCr
16,77716,23616,83918,80719,89021,69125,09826,92030,38931,06031,825
Total Assets
Total AssetsCr
24,35523,61025,87926,90527,68928,33733,84335,08436,75637,78039,031
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
2552552552552552552552552550255
Reserves
ReservesCr
6,6007,65310,84712,08612,64314,03517,99819,46621,98621,33920,951
Current Liabilities
Current LiabilitiesCr
5,0255,6063,7033,9497,0254,4637,0964,9046,0556,1396,743
Non Current Liabilities
Non Current LiabilitiesCr
9,8777,4738,3567,7007,0028,7317,5909,5387,5879,14010,113
Total Liabilities
Total LiabilitiesCr
24,35523,61025,87926,90527,68928,33733,84335,08436,75637,78039,031
Current Assets
Current AssetsCr
7,5797,3749,0408,0987,7996,6468,7458,1646,3676,7207,206
Non Current Assets
Non Current AssetsCr
16,77716,23616,83918,80719,89021,69125,09826,92030,38931,06031,825
Total Assets
Total AssetsCr
24,35523,61025,87926,90527,68928,33733,84335,08436,75637,78039,031

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
2,3323,5311,8701,5811,7802,0371,6442,9713,0161,7611,269
Investing Cash Flow
Investing Cash FlowCr
-489-9822,707-1,958-2,368-1,130-836-1,186-610-1,681-809
Financing Cash Flow
Financing Cash FlowCr
-1,802-2,341-2,089-1,712-129-1,456-755-2,076-2,49429-670
Net Cash Flow
Net Cash FlowCr
422072,488-2,089-717-54953-291-88109-210
Free Cash Flow
Free Cash FlowCr
1,6452,8881,1405026118043791,4271,193-191129
CFO To PAT
CFO To PAT%
250.2315.1119.9136.0173.1467.0117.4121.2671.7497.5-74.0
CFO To EBITDA
CFO To EBITDA%
111.5168.685.488.891.3135.871.377.7105.990.270.3
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
2,3323,5311,8701,5811,7802,0371,6442,9713,0161,7611,269
Investing Cash Flow
Investing Cash FlowCr
-489-9822,707-1,958-2,368-1,130-836-1,186-610-1,681-809
Financing Cash Flow
Financing Cash FlowCr
-1,802-2,341-2,089-1,712-129-1,456-755-2,076-2,49429-670
Net Cash Flow
Net Cash FlowCr
422072,488-2,089-717-54953-291-88109-210
Free Cash Flow
Free Cash FlowCr
1,6452,8881,1405026118043791,4271,193-191129
CFO To PAT
CFO To PAT%
250.2315.1119.9136.0173.1467.0117.4121.2671.7497.5-74.0
CFO To EBITDA
CFO To EBITDA%
111.5168.685.488.891.3135.871.377.7105.990.270.3

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
9,50915,25617,24114,9675,68119,13924,82624,76827,52922,03914,85617,171
Price To Earnings
Price To Earnings
12.315.47.112.90.874.719.810.7102.893.8
Price To Sales
Price To Sales
0.61.51.61.40.51.81.91.41.81.41.01.1
Price To Book
Price To Book
1.41.91.61.20.41.31.41.31.21.00.70.8
EV To EBITDA
EV To EBITDA
8.08.98.310.24.716.413.38.011.414.612.414.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
44.359.261.257.858.353.353.842.141.637.437.437.4
OPM
OPM%
14.120.221.317.218.814.718.322.818.513.112.411.3
NPM
NPM%
6.310.815.211.39.94.311.114.62.92.4-11.8-13.0
ROCE
ROCE%
11.113.611.710.38.64.77.812.14.93.8-3.0-3.0
ROE
ROE%
13.614.214.19.48.03.07.712.42.01.7-8.1-8.1
ROA
ROA%
3.84.86.04.33.71.54.17.01.20.9-4.4-4.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
9,50915,25617,24114,9675,68119,13924,82624,76827,52922,03914,85617,171
Price To Earnings
Price To Earnings
12.315.47.112.90.874.719.810.7102.893.8
Price To Sales
Price To Sales
0.61.51.61.40.51.81.91.41.81.41.01.1
Price To Book
Price To Book
1.41.91.61.20.41.31.41.31.21.00.70.8
EV To EBITDA
EV To EBITDA
8.08.98.310.24.716.413.38.011.414.612.414.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
44.359.261.257.858.353.353.842.141.637.437.437.4
OPM
OPM%
14.120.221.317.218.814.718.322.818.513.112.411.3
NPM
NPM%
6.310.815.211.39.94.311.114.62.92.4-11.8-13.0
ROCE
ROCE%
11.113.611.710.38.64.77.812.14.93.8-3.0-3.0
ROE
ROE%
13.614.214.19.48.03.07.712.42.01.7-8.1-8.1
ROA
ROA%
3.84.86.04.33.71.54.17.01.20.9-4.4-4.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
- **Tata Chemicals is a global chemistry company that began in 1939 by extracting value from the ocean at Mithapur, Gujarat, and now serves customers across five continents as the world’s third-largest soda ash producer.** It transformed from a diversified Indian chemical maker into a focused B2B enterprise after demerging its consumer salt and spices business in 2019, a move that sharpened its identity around industrial and specialty chemistry. The recurring logic behind its evolution is a deliberate push to grow “non-soda ash revenue” - layering steadier, value-added products like pharma-grade bicarbonate, specialty silica, and prebiotics on top of the cyclical soda ash foundation, using the cash flows of one stage to build the next. # Business segments Three engines at different stages - a global soda ash backbone, a set of specialty chemistry platforms built on that backbone, and an agri-science subsidiary with its own listed identity - each designed to reduce the cyclicality of the one before. ## 1. Basic Chemistry: the soda ash backbone that funds everything else **The company makes the essential alkali that goes into glass, detergents, and now solar panels, with more than two-thirds of its capacity coming from lower-cost natural sources in the US and Kenya rather than synthetic plants.** - **Natural soda ash is the cost advantage** - the US facility in Wyoming sits on the world’s largest trona deposits and runs at 2.54 million tonnes of annual capacity, while the Kenya operation at Lake Magadi adds another 400,000 tonnes, both using mining rather than the energy-intensive Solvay process required in India and the UK. That means lower manufacturing costs and a smaller environmental footprint for the bulk of its output. - **Bicarbonate turns a commodity into grades** - the company is the world’s sixth-largest sodium bicarbonate producer, selling the same molecule under four different brand names depending on purity: food grade, feed grade, industrial grade, and pharma grade. Indian bicarbonate capacity reached 290,000 tonnes after a recent expansion, and demand from emission-control applications - scrubbing SO₂ and HCl from industrial exhaust - is less cyclical than soda ash because it is driven by environmental regulation. - **Salt locks in a captive customer** - the company is India’s largest producer of vacuum evaporated iodised salt with 1.6 million tonnes of capacity, and it holds a 50% share of the UK pure-dried vacuum salt market. A 25-year “take or pay” agreement with Tata Consumer Products provides a guaranteed offtake floor, while a new greenfield plant at Valinokkam in Tamil Nadu creates a second production site beyond Mithapur. - **The UK pivoted from making to sourcing** - the Lostock soda ash plant in the UK was closed in January 2025 to stop losses, and the US unit is contracted to supply about 150,000 tons annually to the UK market while the UK operation focuses its domestic manufacturing on high-purity bicarbonate and pharmaceutical-grade salt. A carbon-capture unit at Winnington grabs CO₂ from the on-site power plant to make net-zero bicarbonate, cutting emissions by 40,000 tonnes a year. ## 2. Specialty Products: the non-cyclical growth layer **Three science-driven businesses - silica for tyres, prebiotic fibre for food, and crop protection for farms - that together grew 14% in a year and are designed to be steadier than the soda ash cycle.** - **Silica rides the radial-tyre shift** - the Cuddalore plant in Tamil Nadu is the only silica facility in South India’s automotive hub, making highly dispersible silica that tyre manufacturers need for radial passenger, truck, and bus tyres. Capacity is 10,800 tonnes now, utilisation increased to 79% from 70%, and a planned expansion aims to multiply capacity fivefold over the next three years. - **Prebiotics owns the Indian market** - the FOSSENCE® brand of fructooligosaccharides, a dietary fibre that feeds gut bacteria, holds over 90% market share in India and is made at a dedicated fermentation plant in Andhra Pradesh using in-house technology. The business grew more than 20% in FY26, added capacity for a new product grade, and began exporting to China and Japan while securing key accounts in baby food and confectionery domestically. - **Rallis reaches the farm gate** - Rallis India, a separately listed subsidiary in which Tata Chemicals holds a 55% stake, is one of India’s top ten agrochemical companies and reaches more than 80% of the country’s agricultural districts through 7,200-plus dealers and 95,000-plus retailers. It makes active ingredients like Acephate and Metribuzin for export to over 30 countries, runs a seed business supported by roughly 1,800 seed villages, and launched 11 new crop protection products and 30 new seed products in FY26. - **Novabay opens the pharma-grade door** - the acquisition of a Singapore bicarbonate plant completed in March 2026 adds 60,000 tonnes of premium capacity that holds cGMP and API certifications, meaning it can supply into pharmaceutical formulations and haemodialysis solutions. It is among the largest premium bicarbonate producers in Asia-Pacific outside China, with room to expand to 100,000 tonnes. ## 3. Cement: the circular-economy co-product **Cement is not a standalone strategy but a by-product of making soda ash - the solid waste from the Mithapur process becomes half a million tonnes of saleable cement, turning a disposal cost into a revenue line.** - **Waste becomes product** - the Mithapur soda ash plant generates solid residue that is processed into cement at a 500,000-tonne-per-year unit, operating on a circular-economy model where one process’s output feeds another. # Technology and innovation backbone **A shared R&D and digital infrastructure that serves every segment - from battery-grade lithium processes to AI-driven plant optimisation - with 169 scientists and 468 cumulative patents.** - **Process know-how is the invisible asset** - the company has developed in-house technology for integrated sodium-derivative manufacturing, fermentation-based prebiotics, and a method to recover battery-grade lithium carbonate at over 99.5% purity, while also testing sodium-ion battery technology. - **Digital twins run the plants** - an IoT-based process twin at the lime kiln provides real-time monitoring via mobile dashboards, and a federated AI Centre of Excellence is being built to scale predictive maintenance, GenAI-enabled diagnostics, and safety analytics across operations. - **One digital core connects the globe** - the company deployed SAP S/4HANA as a unified cloud platform integrated with procurement and logistics systems, established an enterprise data warehouse on Microsoft Fabric, and opened a Global Capability Centre at GIFT City in Gujarat for customer-facing operations. # Group structure and partners **A parent company with 23 subsidiaries, three joint ventures, and one associate, anchored by large operating entities in the US, UK, and Kenya that hold the natural-resource assets.** - **North America is the crown jewel** - Tata Chemicals North America Inc. runs the Wyoming trona-mining and soda ash operation with 2.54 million tonnes of annual capacity, the single largest site in the group. The company exited the ANSAC export consortium at the end of 2022 to build its own direct customer relationships for roughly half its US export business. - **The UK is a salt and bicarbonate hub** - TCE Group Limited and British Salt Limited operate the remaining UK assets after the Lostock soda ash closure, including 430,000 tonnes of salt capacity and a separate 70,000 tonnes of pharmaceutical salt capacity. - **Africa and Asia fill out the map** - Tata Chemicals Magadi Limited produces soda ash from Lake Magadi’s trona in Kenya, while the Singapore subsidiary holds the newly acquired Novabay premium bicarbonate plant. A Moroccan joint venture, Indo Maroc Phosphore, paid dividends of ₹125 crore in FY26. - **The structure has been simplified** - holding-company reorganisations in the US and UK during 2023 and 2026 reduced intermediate entities without changing ultimate ownership, and two non-operational UK subsidiaries were dissolved in April 2026.

Documents — Tata Chemicals Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/y51qrqirlrtwmlr2kyq6vpmn.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/z3j292kbusrv5w5al726wfw6.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/abecegfan8825fxxp3e9tucg.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/wap0guj43tkknfy6gscm17xk.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/ufr5drtrvy24f7svvtwbktxa.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/c11bm3rlhb2q378akfbu02dp.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/oykcb66l6tzczd4sjtky6h5y.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/2hga5ie1tpttiecpert7r13p.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/glitmhdj4utrc86v5il48z1d.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/7jqzpfjo7loy3y2d671l4j0d.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/5ywhfo1g2polaizvt20e9maa.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/jokph3oxt5eucdgbpedi0kif.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/o2apzii89rwmm6ovk012vs8o.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/kntwit5vrb26jh6bgdu13rta.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/skl96atbpuv0nx58148xkr31.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/arke60fh6kkmarnbqy873pvk.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/4qcqaiiwsxlztge5wvqy5oa4.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/ij7wssvikuc0zbtk4blqdzjh.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/rzshkgjecufdxpknpdui22v3.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/kszoq8ew63n8nar4pyky0ont.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/vbo46633vxop11g13fxvuqtk.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/qbrqn402scg9ee8yo9tpsh4k.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/x0z5tpys0zcuu370kqerccvg.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/pmczdbl9da30lmhi0aja4d8m.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/2e07j4psnj7ykizkf48s6pvb.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/adkxdsj69rblteuxs4b6m34u.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/f82692upzbw8qty1dzt65sgr.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/64hgnvkmursxzvgq3lwbwv7t.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/5ar2fu2gbk2jiwbehy73r91c.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/uf79m7ank2zix3puvjr85qcn.pdf

Concall Transcript Summaries — Tata Chemicals Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3ATATACHEM/transcript-notes/202606/y51qrqirlrtwmlr2kyq6vpmn.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3ATATACHEM/transcript-notes/202603/z3j292kbusrv5w5al726wfw6.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3ATATACHEM/transcript-notes/202512/abecegfan8825fxxp3e9tucg.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ATATACHEM/transcript-notes/202509/wap0guj43tkknfy6gscm17xk.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3ATATACHEM/transcript-notes/202506/ufr5drtrvy24f7svvtwbktxa.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3ATATACHEM/transcript-notes/202503/c11bm3rlhb2q378akfbu02dp.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3ATATACHEM/transcript-notes/202412/oykcb66l6tzczd4sjtky6h5y.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3ATATACHEM/transcript-notes/202409/2hga5ie1tpttiecpert7r13p.pdf